院内感染対策の世界市場レポート (2024年)

院内感染対策の市場規模は、今後数年間で着実に成長する見通しです。今後は4.8%の年間複合成長率 (CAGR) で成長し、2028年には413億7,000万米ドルに達すると予想されます。予測期間中に予想される拡大は、多剤耐性病原体の増加、パンデミックへの備え、監視・モニタリングの強化、AS (抗菌薬適正使用支援) プログラム、国際協力に関連している可能性があります。予測期間中に予測される主な動向には、リアルタイム位置情報システム (RTLS) の採用、監視用の人工知能 (AI) の統合、使い捨てデバイスへの移行、スタッフのトレーニングと教育の重視、UV-Cやその他の消毒技術の利用増加などが含まれます。

院内感染対策市場は、COVID-19感染症の感染者数の急増により成長すると予想されています。 SARS-CoV-2ウイルスによって引き起こされる新型コロナウイルス感染症 (COVID-19) は、個人の衛生管理と医療用品の生産を重視した、感染対策製品・サービスの需要の増加につながりました。世界保健機関によると、2022年8月8日の時点で世界のCOVID-19感染者数は5億8,160万人に達しており、パンデミックの進行による市場の拡大を裏付けています。

院内感染対策市場は、医療費の増加見通しによって成長すると考えられています。医療費には、指定された期間における医療関連のサービス・製品・活動に対する支出の合計が含まれます。医療費の増加に伴い、病院や医療施設は、高度な消毒システムやスマート監視デバイスなどの革新的なソリューションを含む高度な感染予防技術の導入に追加のリソースを割り当てると予想されます。たとえば、2023年5月に英国国家統計局は、医療費が9.4%増加し、2021年には総額3,672億5,000万米ドル (2,807億英ポンド) に達すると報告しました。医療費の大幅な増加は、院内感染対策市場を推進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の院内感染対策市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の院内感染対策の市場規模と成長の実績、2018～2023年
• 世界の院内感染対策の市場規模と成長の予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の院内感染対策市場、製品別セグメンテーション、実績・予測、2018年～2023年、2023～2028年、2033年
• 滅菌器
• 消毒剤
• 内視鏡再処理装置
• 微生物検査機器
• 消耗品
• 消毒剤
• 感染予防・監視ソフトウェア
• その他の製品
• 世界の院内感染対策市場、技術別セグメンテーション、実績・予測、2018年～2023年、2023～2028年、2033年
• 表現型の解析法
• 遺伝子型の解析法
• 世界の院内感染対策市場、疾患別セグメンテーション、実績・予測、2018年～2023年、2023～2028年、2033年
• 院内肺炎
• 血流感染症
• 手術部位の感染症
• 胃腸感染症
• 尿路感染症
• その他の疾患
• 世界の院内感染対策市場、用途別セグメンテーション、実績・予測、2018年～2023年、2023～2028年、2033年
• 疾患検査
• 薬剤耐性検査
• 世界の院内感染対策市場、エンドユーザー別セグメンテーション、実績・予測、2018年～2023年、2023～2028年、2033年
• 病院
• ICU (集中治療室)
• 外来サービス
• 診断センター
• 養護施設
• マタニティセンター
• その他のエンドユーザー

第7章 地域別・国別の分析

• 世界の院内感染対策市場、地域別、実績・予測、2018年～2023年、2023～2028年、2033年
• 世界の院内感染対策市場、国別、実績・予測、2018年～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 院内感染対策市場の競合情勢
• 院内感染対策市場の企業プロファイル
  • Johnson and Johnson
  • P&G Professional
  • Honeywell International Inc.
  • MMM Group
  • 3M Company

第31章 その他の主要および革新的な企業

• Becton Dickinson and Company
• Reckitt Benckiser Group plc.
• Ecolab Inc
• Olympus Corporation
• Miele Group
• Biomerieux SA
• Getinge AB
• Halyard Health Inc.
• Ansell Limited
• Sotera Health LLC
• Contec Inc.
• Cantel Medical Corp.
• Belimed AG
• Sterigenics International LLC
• Nanosonics Limited

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Hospital-acquired infections, acquired during hospital care and absent before admission, are managed through hospital-acquired infection control, employing cleaning, sterilization, and disinfection methods to reduce or eliminate transmission. These infections may stem from cross-contamination involving equipment surfaces, patient skin, and healthcare staff. The goal of hospital-acquired infection control is to curb the spread of illnesses.

The primary types of products in hospital-acquired infection control encompass sterilizers, disinfectors, endoscope reprocessors, microbial testing instruments, reagents, consumables, disinfectants, infection prevention and surveillance software, and others. Sterilizers, machines designed to thoroughly cleanse and eliminate bacteria, are employed to kill germs on surfaces or in fluids, preventing disease transmission. Various technologies, including phenotypic and genotypic methods, address diseases such as hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections, and others. Applications range from disease testing to drug-resistance testing, with end users including hospitals, ICUs, ambulatory surgical and diagnostic centers, nursing homes, maternity centers, and others.

The hospital-acquired infection control market research report is one of a series of new reports from The Business Research Company that provides hospital-acquired infection control market statistics, including hospital-acquired infection control industry global market size, regional shares, competitors with a hospital-acquired infection control market share, detailed hospital-acquired infection control market segments, market trends and opportunities, and any further data you may need to thrive in the hospital-acquired infection control industry. This hospital-acquired infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hospital-acquired infection control market size has grown steadily in recent years. It will grow from $33.01 billion in 2023 to $34.35 billion in 2024 at a compound annual growth rate (CAGR) of 4.1%. The increase observed in the historical period can be ascribed to increasing antibiotic resistance, growing awareness, stringent regulations, the globalization of infectious diseases, and patient safety initiatives.

The hospital-acquired infection control market size is expected to see steady growth in the next few years. It will grow to $41.37 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The expansion anticipated in the forecast period can be linked to the rise of multidrug-resistant pathogens, pandemic preparedness, increased surveillance and monitoring, antimicrobial stewardship programs, and international collaboration. Major trends projected for the forecast period encompass the adoption of real-time location systems (RTLS), integration of artificial intelligence (AI) for surveillance, a shift towards single-use and disposable devices, emphasis on staff training and education, and increased utilization of UV-C and other disinfection technologies.

The hospital-acquired infection control market is anticipated to experience growth driven by the surge in COVID-19 cases. COVID-19, caused by the SARS-CoV-2 virus, has led to an increased demand for infection control products and services, emphasizing personal hygiene and the production of medical supplies. As of August 8, 2022, global COVID-19 cases reached 581.6 million, according to the World Health Organization, underscoring the market's expansion due to the ongoing pandemic.

The hospital-acquired infection control market is poised for growth, driven by the anticipated increase in healthcare expenditures. Healthcare expenditures encompass the total spending on healthcare-related services, products, and activities over a specified period. With a rise in healthcare spending, hospitals and healthcare facilities are expected to allocate additional resources for the adoption of advanced infection prevention technologies, including innovative solutions such as advanced disinfection systems and smart monitoring devices. For example, in May 2023, the UK's Office for National Statistics reported a 9.4% increase in healthcare spending, totaling $367.25 billion (£280.7 billion) in 2021. The substantial growth in healthcare expenditure is expected to propel the hospital-acquired infection control market.

Premier companies are at the forefront of the hospital-acquired infection control market, emphasizing technological advancements. These leading players are dedicated to creating innovative technological solutions to take the lead in the market. For example, in November 2021, scientists from the University of Pittsburgh School of Medicine and Carnegie Mellon University employed machine learning technology coupled with whole genome sequencing to rapidly identify infectious disease outbreaks in hospitals. This method detects significant outbreaks that might otherwise escape routine infection prevention monitoring.

Premier companies in the hospital-acquired infection control market are innovating by developing profitable products, such as digital platforms. In this context, a digital platform refers to an integrated and technology-driven solution designed to manage, monitor, and enhance infection prevention and control measures within healthcare facilities. For instance, Nanosonics, an Australia-based healthcare technology provider, launched AuditPro in June 2021. AuditPro is an advanced infection prevention platform tailored for medical settings, particularly focusing on ultrasound procedures. It incorporates a mobile scanning device, a user-friendly app for decision support, real-time risk alerts, and information-packed dashboards. Organizations can choose between the AuditPro Digital Logbook or the Workflow Compliance Management Solution, both seamlessly integrating with the trophon2 device for comprehensive infection prevention.

In June of 2021, Steris Corporation, a US-based medical equipment company specializing in sterilization and surgical products, acquired Cantel Medical for an undisclosed sum. This acquisition is expected to enable Steris to expand its product and service offerings and enhance its global reach. Cantel Medical, a US-based manufacturer of infection prevention products, was the target of this acquisition.

Major companies operating in the hospital-acquired infection control market report are Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc., Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Sterigenics International LLC, Nanosonics Limited, Advanced Sterilization Products Services Inc., Steelco S.P.A, Schulke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd., Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.

North America was the largest region in the hospital-acquired infection control market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hospital-acquired infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hospital-acquired infection control market includes revenues earned by entities by heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, other sterilization equipment, contract sterilization services, sterilization consumables and accessories, disinfectants, and disinfectors equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hospital-Acquired Infection Control Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hospital-acquired infection control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hospital-acquired infection control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hospital-acquired infection control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Sterilizers; Disinfectors; Endoscope Reprocessors; Microbial Testing Instruments; Consumables; Disinfectants; Infection Prevention And Surveillance Software; Other Products
• 2) By Technology: Phenotypic Methods; Genotypic Methods
• 3) By Diseases: Hospital Acquired Pneumonia; Bloodstream Infections; Surgical Site Infections; Gastrointestinal Infections; Urinary Tract Infection; Other Diseases
• 4) By Application: Disease Testing; Drug-Resistance Testing
• 5) By End User: Hospitals; ICUs; Ambulatory Surgical; Diagnostic Centers; Nursing Homes; Maternity Centers; Other End Users
• Companies Mentioned: Johnson and Johnson; P&G Professional; Honeywell International Inc.; MMM Group; 3M Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hospital-Acquired Infection Control Market Characteristics

3. Hospital-Acquired Infection Control Market Trends And Strategies

4. Hospital-Acquired Infection Control Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Hospital-Acquired Infection Control Market Size and Growth

• 5.1. Global Hospital-Acquired Infection Control Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Hospital-Acquired Infection Control Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Hospital-Acquired Infection Control Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hospital-Acquired Infection Control Market Segmentation

• 6.1. Global Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Sterilizers
• Disinfectors
• Endoscope Reprocessors
• Microbial Testing Instruments
• Consumables
• Disinfectants
• Infection Prevention And Surveillance Software
• Other Products
• 6.2. Global Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Phenotypic Methods
• Genotypic Methods
• 6.3. Global Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infection
• Other Diseases
• 6.4. Global Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Disease Testing
• Drug-Resistance Testing
• 6.5. Global Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• ICUs
• Ambulatory Services
• Diagnostic Center
• Nursing Homes
• Maternity Centers
• Other End Users

7. Hospital-Acquired Infection Control Market Regional And Country Analysis

• 7.1. Global Hospital-Acquired Infection Control Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Hospital-Acquired Infection Control Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hospital-Acquired Infection Control Market

• 8.1. Asia-Pacific Hospital-Acquired Infection Control Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hospital-Acquired Infection Control Market

• 9.1. China Hospital-Acquired Infection Control Market Overview
• 9.2. China Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hospital-Acquired Infection Control Market

• 10.1. India Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hospital-Acquired Infection Control Market

• 11.1. Japan Hospital-Acquired Infection Control Market Overview
• 11.2. Japan Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hospital-Acquired Infection Control Market

• 12.1. Australia Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hospital-Acquired Infection Control Market

• 13.1. Indonesia Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hospital-Acquired Infection Control Market

• 14.1. South Korea Hospital-Acquired Infection Control Market Overview
• 14.2. South Korea Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hospital-Acquired Infection Control Market

• 15.1. Western Europe Hospital-Acquired Infection Control Market Overview
• 15.2. Western Europe Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hospital-Acquired Infection Control Market

• 16.1. UK Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hospital-Acquired Infection Control Market

• 17.1. Germany Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hospital-Acquired Infection Control Market

• 18.1. France Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hospital-Acquired Infection Control Market

• 19.1. Italy Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hospital-Acquired Infection Control Market

• 20.1. Spain Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hospital-Acquired Infection Control Market

• 21.1. Eastern Europe Hospital-Acquired Infection Control Market Overview
• 21.2. Eastern Europe Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hospital-Acquired Infection Control Market

• 22.1. Russia Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hospital-Acquired Infection Control Market

• 23.1. North America Hospital-Acquired Infection Control Market Overview
• 23.2. North America Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hospital-Acquired Infection Control Market

• 24.1. USA Hospital-Acquired Infection Control Market Overview
• 24.2. USA Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hospital-Acquired Infection Control Market

• 25.1. Canada Hospital-Acquired Infection Control Market Overview
• 25.2. Canada Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hospital-Acquired Infection Control Market

• 26.1. South America Hospital-Acquired Infection Control Market Overview
• 26.2. South America Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hospital-Acquired Infection Control Market

• 27.1. Brazil Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hospital-Acquired Infection Control Market

• 28.1. Middle East Hospital-Acquired Infection Control Market Overview
• 28.2. Middle East Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hospital-Acquired Infection Control Market

• 29.1. Africa Hospital-Acquired Infection Control Market Overview
• 29.2. Africa Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hospital-Acquired Infection Control Market Competitive Landscape And Company Profiles

• 30.1. Hospital-Acquired Infection Control Market Competitive Landscape
• 30.2. Hospital-Acquired Infection Control Market Company Profiles
  • 30.2.1. Johnson and Johnson
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. P&G Professional
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Honeywell International Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. MMM Group
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. 3M Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Hospital-Acquired Infection Control Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. Reckitt Benckiser Group plc.
• 31.3. Ecolab Inc
• 31.4. Olympus Corporation
• 31.5. Miele Group
• 31.6. Biomerieux SA
• 31.7. Getinge AB
• 31.8. Halyard Health Inc.
• 31.9. Ansell Limited
• 31.10. Sotera Health LLC
• 31.11. Contec Inc.
• 31.12. Cantel Medical Corp.
• 31.13. Belimed AG
• 31.14. Sterigenics International LLC
• 31.15. Nanosonics Limited

32. Global Hospital-Acquired Infection Control Market Competitive Benchmarking

33. Global Hospital-Acquired Infection Control Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hospital-Acquired Infection Control Market

35. Hospital-Acquired Infection Control Market Future Outlook and Potential Analysis

• 35.1 Hospital-Acquired Infection Control Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Hospital-Acquired Infection Control Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Hospital-Acquired Infection Control Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer